Advances in Asthma Management: Integrating Biologics, Personalized Medicine, and Lessons from the COVID-19 Era

Author(s)	Vaibhav Ramdas Jadhav, Akanksha Madhukar Purkar, Nikita Santosh Dukale, Rohit Balkrushna Sonawane, Kunal Sunil Niphade
Country	India
Abstract	Asthma remains a global health challenge, affecting over 300 million individuals. While inhaled corticosteroids (ICS) and short-acting β₂-agonists (SABAs) form the cornerstone of therapy, emerging biologic agents and personalized approaches are revolutionizing care. This review explores recent advancements in biologic therapies targeting specific inflammatory pathways, the role of biomarkers in precision medicine, and the evolving impact of COVID-19 on asthma management. We also evaluate barriers to control, such as poor adherence and phenotypic heterogeneity, and propose strategies to integrate novel therapies into clinical practice. By synthesizing evidence from key trials and epidemiological studies, this work underscores the importance of tailored treatment algorithms to reduce morbidity and mortality.
Keywords	Asthma, Covid-19 Impact, Personalized medicine, Asthma Treatment, Biomarkers, Asthma Management
Field	Medical / Pharmacy
Published In	Volume 7, Issue 2, March-April 2025
Published On	2025-03-02
DOI	https://doi.org/10.36948/ijfmr.2025.v07i02.37923
Short DOI	https://doi.org/g87cz3

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9687-828-838	editor@ijfmr.com

International Journal For Multidisciplinary Research